Top

Journal of Endocrinological Investigation

Published in:

01-01-2021 | COVID-19 | Short Review

Possible role of vitamin D in Covid-19 infection in pediatric population

Authors: F. M. Panfili, M. Roversi, P. D’Argenio, P. Rossi, M. Cappa, D. Fintini

Published in: Journal of Endocrinological Investigation | Issue 1/2021

Abstract

Purpose

Covid-19 is a pandemic of unprecedented proportion, whose understanding and management is still under way. In the emergency setting new or available therapies to contrast the spread of COVID-19 are urgently needed. Elderly males, especially those affected by previous diseases or with comorbidities, are more prone to develop interstitial pneumonia that can deteriorate evolving to ARDS (acute respiratory distress syndrome) that require hospitalization in Intensive Care Units (ICUs). Even children and young patients are not spared by SARS-CoV 2 infection, yet they seem to develop a milder form of disease. In this setting the immunomodulatory role of Vitamin D, should be further investigated. Methods: We reviewed the literature about the immunomodulatory role of Vitamin D collecting data from the databases Medline and Embase.

Results

Vitamin D proved to interact both with the innate immune system, by activating Toll-like receptors (TLRs) or increasing the levels of cathelicidins and β-defensins, and adaptive immune system, by reducing immunoglobulin secretion by plasma cells and pro-inflammatory cytokines production, thus modulating T cells function. Promising results have been extensively described as regards the supplementation of vitamin D in respiratory tract infections, autoimmune diseases and even pulmonary fibrosis.

Conclusions

In this review, we suggest that vitamin D supplementation might play a role in the prevention and/or treatment to SARS-CoV-2 infection disease, by modulating the immune response to the virus both in the adult and pediatric population.

World Health Organization. Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 11 Mar 2019

Remuzzi A, Remuzzi G (2020) COVID-19 and Italy: what next? Lancet. https://doi.org/10.1016/S0140-6736(20)30627(Health Policy Online First, publ March 13)CrossRefPubMedPubMedCentral

Wu Z, McGoogan JM (2020) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA. https://doi.org/10.1001/jama.2020.2648CrossRefPubMedPubMedCentral

Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of Coronavirus Disease 2019 in China [published online ahead of print, 2020 Feb 28]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032CrossRefPubMedPubMedCentral

Lu X, Zhang L, Du H et al (2020) SARS–CoV-2 infection in children [published online ahead of print, 2020 Mar 18]. N Engl J Med. https://doi.org/10.1056/NEJMc2005073CrossRefPubMedPubMedCentral

Dong Y, Mo X, Hu Y et al (2020) Epidemiology of COVID-19 among children in China [published online ahead of print, 2020 Mar 16]. Pediatrics. https://doi.org/10.1542/peds.2020-0702CrossRefPubMedPubMedCentral

Holick MF (1678S) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–S1688. https://doi.org/10.1093/ajcn/80.6.1678SCrossRefPubMed

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385CrossRefPubMed

Munns CF, Shaw N, Kiely M et al (2016) Global consensus recommendations on prevention and management of nutritional rickets. Horm Res Paediatr 85(2):83–106. https://doi.org/10.1159/000443136CrossRefPubMed

10.

Rossi P, Chini L, Fattorossi A et al (1987) 1,25-Dihydroxyvitamin D3 and phorbol esters (TPA) may induce select in vitro differentiation pathways in the HL60 promyelocytic cell line. Clin Immunol Immunopathol 44(3):308–16CrossRefPubMed

11.

Baeke F, Takiishi T, Korf H, Lemire JM, Archer DC, Beck L, Spielberg HL et al (1995) Vitamin D: modulator of the immune system. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibitions of Th1 functions. J Nutr 125:1704–8

12.

Lemire JM (1992) Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49(1):26–31. https://doi.org/10.1002/jcb.240490106CrossRefPubMed

13.

Liu PT, Stenger S, Li H et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768):1770–1773. https://doi.org/10.1126/science.1123933CrossRefPubMed

14.

Teymoori-Rad M, Shokri F, Salimi V, Marashi SM (2019) The interplay between vitamin D and viral infections. Rev Med Virol 29(2):e2032. https://doi.org/10.1002/rmv.2032[6]CrossRefPubMed

15.

Hsieh E, Yin MT (2018) Continued interest and controversy: vitamin D in HIV. Curr HIV/AIDS Rep 15(3):199–211. https://doi.org/10.1007/s11904-018-0401-4CrossRefPubMedPubMedCentral

16.

Alvarez N, Aguilar-Jimenez W, Rugeles MT (2019) The potential protective role of vitamin D supplementation on HIV-1 infection. Front Immunol 10:2291. https://doi.org/10.3389/fimmu.2019.02291CrossRefPubMedPubMedCentral

17.

Eckard AR, O'Riordan MA, Rosebush JC (2018) Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther 23(4):315–324. https://doi.org/10.3851/IMP3199CrossRefPubMedPubMedCentral

18.

Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of vitamin D depend on the differentiation and activation status of CD4-positive T-cells. J Cell Biochem 89:922–932CrossRefPubMed

19.

Zhang Y, Leung DY, Richers BN et al (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188:2127–2135. https://doi.org/10.4049/jimmunol.1102412CrossRefPubMed

20.

Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647CrossRefPubMed

21.

https://www.who.int/news-room/fact-sheets/detail/pneumonia. Accessed 2 Aug 2019

22.

Zhou YF, Luo BA, Qin LL (2019) The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies. Medicine (Baltimore) 98(38):e17252. https://doi.org/10.1097/MD.0000000000017252CrossRef

23.

Gruber-Bzura BM (2018) Vitamin D and influenza-prevention or therapy? Int J Mol Sci 19(8):2419. https://doi.org/10.3390/ijms19082419(Published 2018 Aug 16)CrossRefPubMedCentral

24.

Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA (2017) Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. https://doi.org/10.1002/rmv.1909CrossRefPubMed

25.

Martineau AR, Jolliffe DA, Hooper RL et al (2017) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356:i6583. https://doi.org/10.1136/bmj.i6583(Published 2017 Feb 15)CrossRefPubMedPubMedCentral

26.

Esposito S, Lelii M (2015) Vitamin D and respiratory tract infections in childhood. BMC Infect Dis 15:487. https://doi.org/10.1186/s12879-015-1196-1CrossRefPubMedPubMedCentral

27.

Das RR, Singh M, Naik SS (2018) Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia. Cochrane Database Syst Rev 7(7):CD011597. https://doi.org/10.1002/14651858.CD011597.pub2(Published 2018 Jul 19)CrossRefPubMed

28.

Del-Rio-Navarro BE, Espinosa Rosales F, Flenady V, Sienra-Monge JJ (2006) Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004974.pub2(Published 2006 Oct 18)CrossRefPubMed

29.

Aglipay M, Birken CS, Parkin PC et al (2017) Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA 318(3):245–254. https://doi.org/10.1001/jama.2017.8708CrossRefPubMedPubMedCentral

30.

Pletz MW, Terkamp C, Schumacher U et al (2014) Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respir Res 15(1):53. https://doi.org/10.1186/1465-9921-15-53(Published 2014 Apr 27)CrossRefPubMedPubMedCentral

31.

Miroliaee AE, Salamzadeh J, Shokouhi S, Sahraei Z (2018) The study of vitamin D administration effect on CRP and interleukin-6 as prognostic biomarkers of ventilator associated pneumonia. J Crit Care 44:300–305. https://doi.org/10.1016/j.jcrc.2017.08.040CrossRefPubMed

32.

Altieri B, Muscogiuri G, Barrea L et al (2017) Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord. https://doi.org/10.1007/s11154-016-9405-9CrossRefPubMed

33.

Skaaby T, Husemoen LL, Thuesen BH, Linneberg A (2015) Prospective population based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine 50:231–238CrossRefPubMed

34.

Xiong J, He Z, Zeng X, Zhang Y, Hu Z (2014) Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Clin Exp Rheumatol 32:174–181PubMed

35.

Mosaad YM, Hammad EM, Fawzy Z et al (2014) Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum Immunol 75:452–461CrossRefPubMed

36.

Bizzaro G, Antico A, Fortunato A, Bizzaro N (2017) Vitamin D and autoimmune diseases: is vitamin D receptor (VDR) polymorphism the culprit? Isr Med Assoc J 19(7):438–443PubMed

37.

Amital H, Szekanecz Z, Szucs G et al (2010) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69:1155–1157CrossRefPubMed

38.

Ilescas-Montes R, Melguizo-Rodríguez L, Ruiz C et al (2019) Vitamin D and autoimmune diseases 2019. Life Sci 233:116744. https://doi.org/10.1016/j.lfs.2019.116744CrossRef

39.

Zerr P, Vollath S, Palumbo-Zerr K et al (2015) Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. Ann Rheum Dis 74(3):e20. https://doi.org/10.1136/annrheumdis-2013-204378CrossRefPubMed

40.

Chandrashekara S, Patted A (2017) Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: an exploratory study. Int J Rheum Dis 20(7):825–831. https://doi.org/10.1111/1756-185X.12770CrossRefPubMed

41.

Aslam MM, John P, Bhatti A, Jahangir S, Kamboh MI (2019) Vitamin D as a principal factor in mediating rheumatoid arthritis-derived immune response. Biomed Res Int. https://doi.org/10.1155/2019/3494937(Published 2019 May 7)CrossRefPubMedPubMedCentral

42.

Sengler C, Zink J, Klotsche J et al (2018) Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis—data from a German inception cohort. Arthritis Res Ther 20(1):276CrossRefPubMedPubMedCentral

43.

Finch SL, Rosenberg AM, Vatanparast H (2018) Vitamin D and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 16(1):34 (Published 2018 May 16)CrossRefPubMedPubMedCentral

44.

Verdoni L, Mazza A, Gervasoni A et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS–CoV-2 epidemic: an observational cohort study [published online ahead of print, 2020 May 13]. Lancet. https://doi.org/10.1016/S0140-6736(20)31103-XCrossRefPubMedPubMedCentral

45.

Stagi S, Rigante D, Lepri G, Matucci Cerinic M, Falcini F (2016) Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? Clin Rheumatol 35(7):1865–1872CrossRefPubMed

46.

Jun JS, Jung YK, Lee DW (2017) Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease. Korean J Pediatr 60(7):216–220. https://doi.org/10.3345/kjp.2017.60.7.216CrossRefPubMedPubMedCentral

47.

Tsujino I, Ushikoshi-Nakayama R, Yamazaki T, Matsumoto N, Saito I (2019) Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia. J Clin Biochem Nutr 65(3):245–251. https://doi.org/10.3164/jcbn.19-48CrossRefPubMedPubMedCentral

48.

Tzilas V, Bouros E, Barbayianni I et al (2019) Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 55:17–24. https://doi.org/10.1016/j.pupt.2019.01.003CrossRefPubMed

49.

Shi Y, Liu T, Yao L et al (2017) Chronic vitamin D deficiency induces lung fibrosis through activation of the renin–angiotensin system. Sci Rep 7(1):3312. https://doi.org/10.1038/s41598-017-03474-6(Published 2017 Jun 12)CrossRefPubMedPubMedCentral

50.

Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A (2008) Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res 28(5A):2613–2623PubMed

51.

COVID-19 National Incident Room Surveillance Team (2020) COVID-19, Australia: Epidemiology Report 6 (Reporting week ending 19:00 AEDT 7 March 2020). Commun Dis Intell (2018). https://doi.org/10.33321/cdi.2020.44.21(Published 2020 Mar 11)CrossRef

52.

Zhang L, Liu Y (2020) Potential interventions for novel coronavirus in China: a systematic review. J Med Virol 92(5):479–490. https://doi.org/10.1002/jmv.25707CrossRefPubMedPubMedCentral

53.

Nonnecke BJ, McGill JL, Ridpath JF, Sacco RE, Lippolis JD, Reinhardt TA (2014) Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves. J Dairy Sci 97:5566–5579CrossRefPubMed

54.

Myers RM, Kadauke S, Li Y, Callahan CA, Gladney W, Fitzgerald JC, McGuire R (2020) Risk-adapted preemptive tocilizumab decreases severe cytokine release syndrome (CRS) after CTL019 CD19-targeted chimeric antigen receptor (CAR) T-cell therapy for pediatric B-cell acute lymphoblastic leukemia (B-ALL). Biol Blood Marrow Transplant 26(3):S39CrossRef

55.

Tanaka T, Narazaki M, Kishimoto T (2016) Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 8(8):959–970. https://doi.org/10.2217/imt-2016-0020CrossRefPubMed

56.

Pedersen SF, Ho YC (2020) SARS–CoV-2: a storm is raging [published online ahead of print, 2020 Mar 27]. J Clin Investig. https://doi.org/10.1172/JCI137647CrossRefPubMedPubMedCentral

57.

Channappanavar R, Perlman S (2017) Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 39(5):529–539. https://doi.org/10.1007/s00281-017-0629-xCrossRefPubMedPubMedCentral

58.

ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 Mar 8—Identifier NCT04306705, Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 (TACOS); 2020 Mar 12; [about 4 screens]. https://clinicaltrials.gov/ct2/show/NCT04306705?cond=tocilizumab+AND+covid&draw=2&rank=1. Accessed 15 Mar 2020

59.

ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 Mar 20—Identifier NCT04317092, Multicenter Study on the Efficacy and Tolerability of Tocilizumab in the Treatment of Patients With COVID-19 Pneumonia (TOCIVID-19); 2020 Mar 20; [about 5 screens]. https://clinicaltrials.gov/ct2/show/NCT04317092?cond=TOCIVID&draw=2&rank=1. Accessed 20 Mar 2020

60.

Kim H, Baek S, Hong SM et al (2020) 1,25-Dihydroxy vitamin D3 and interleukin-6 blockade synergistically regulate rheumatoid arthritis by suppressing interleukin-17 production and osteoclastogenesis. J Korean Med Sci 35(6):e40. https://doi.org/10.3346/jkms.2020.35.e40CrossRefPubMedPubMedCentral

61.

Thompson BT, Chambers RC, Liu KD (2017) Acute respiratory distress syndrome. N Engl J Med 377(19):1904–1905. https://doi.org/10.1056/NEJMc1711824CrossRefPubMed

62.

Zacharova I, Klimov L, Kuryaninova V et al (2019) Vitamin D insufficiency in overweight and obese children and adolescents. Front Endocrinol. https://doi.org/10.3389/fendo.2019.00103CrossRef

63.

Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626–638. https://doi.org/10.1038/nri.2016.90CrossRefPubMed

64.

Cuotolo M, Paolino S, Sulli A et al (2014) Vitamin D, steroid hormones, and autoimmunity. Ann N Y Acad Sci 1317:39–46. https://doi.org/10.1111/nyas.12432CrossRef

65.

Alipio M (2020) Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-19). Available at SSRN: https://ssrn.com/abstract=3571484 or https://doi.org/10.2139/ssrn.3571484

66.

Grant WB, Lahore H, McDonnell SL et al (2020) Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12(4):E988. https://doi.org/10.3390/nu12040988CrossRefPubMed

67.

McCartney DM, Byrne DG (2020) Optimisation of vitamin D status for enhanced immuno-protection against Covid-19. Ir Med J 113(4):58PubMed

68.

ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 Apr 3—Identifier NCT04334005, Effect of Vitamin D Administration on Prevention and Treatment of Mild Forms of Suspected Covid-19 (COVITD-19), 2020 Apr 7; [about 3 screens]. https://clinicaltrials.gov/ct2/show/NCT04334005. Accessed 13 Apr 2020

69.

Panarese A, Shaini E (2020) Letter: Covid-19, and vitamin D. Aliment Pharmacol Ther. https://doi.org/10.1111/apt.15752CrossRefPubMedPubMedCentral

70.

Caccialanza R, Laviano A, Lobascio F et al (2020) Early Nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol. Nutrition. https://doi.org/10.1016/j.nut.2020.110835CrossRefPubMedPubMedCentral

Title: Possible role of vitamin D in Covid-19 infection in pediatric population
Authors: F. M. Panfili
M. Roversi
P. D’Argenio
P. Rossi
M. Cappa
D. Fintini
Publication date: 01-01-2021
Publisher: Springer International Publishing
Keywords: COVID-19
Pneumonia
Cytokines
Published in: Journal of Endocrinological Investigation / Issue 1/2021
Electronic ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-020-01327-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Assessment of simple strategies for identifying undiagnosed diabetes and prediabetes in the general population

Disorders of sexual development with XY karyotype and female phenotype: clinical findings and genetic background in a cohort from a single centre

Insufficient glucocorticoid receptor signaling and flattened salivary cortisol profile are associated with metabolic and inflammatory indices in type 2 diabetes

Association of left ventricular hypertrophy with the level of thyroid hormone in euthyroid state

Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSH

Molecular skin changes in Cushing syndrome and the effects of treatment

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials